![Sanjay K. Kakkar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sanjay K. Kakkar
Directeur Général chez
Tensive Srl
Profil
Sanjay K.
Kakkar currently works at Tensive Srl, as Chief Executive Officer from 2025.
Dr. Kakkar also formerly worked at Trigen Holdings AG, as Chief Executive Officer from 1997 to 2009, Armetheon, Inc., as Chief Executive Officer, Peptilogics, Inc., as Chief Executive Officer & Director, Tranquis Therapeutics, Inc., as President & Chief Executive Officer, Novartis Corp., as Product Manager, and Pharmacia, Inc., as Principal.
Dr. Kakkar received his graduate degree from Harvard University, graduate degree from Imperial College London, and doctorate degree from King's College London.
Postes actifs de Sanjay K. Kakkar
| Sociétés | Poste | Début |
|---|---|---|
Tensive Srl
 Tensive Srl Pharmaceuticals: MajorHealth Technology Develops innovative prostheses aiming to offer a natural breast reconstruction or augmentation | Directeur Général | 30/01/2025 |
Anciens postes connus de Sanjay K. Kakkar
| Sociétés | Poste | Fin |
|---|---|---|
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | President | 15/12/2009 |
Tranquis Therapeutics, Inc.
 Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immuno-therapeutics for neurological diseases | Directeur Général | - |
Peptilogics, Inc.
 Peptilogics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in growing global epidemic drug from multidrug resistant infections | Directeur Général | - |
Armetheon, Inc.
 Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Directeur Général | - |
Pharmacia, Inc. | Corporate Officer/Principal | - |
Formation de Sanjay K. Kakkar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Commercial Services |
Pharmacia, Inc. | |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Health Technology |
Peptilogics, Inc.
Peptilogics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in growing global epidemic drug from multidrug resistant infections | Commercial Services |
Tensive Srl
Tensive Srl Pharmaceuticals: MajorHealth Technology Develops innovative prostheses aiming to offer a natural breast reconstruction or augmentation | Health Technology |
Tranquis Therapeutics, Inc.
Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immuno-therapeutics for neurological diseases | Health Technology |
Choisissez Zonebourse 
